Synthetic biology approaches to engineer T cells
- PMID: 26218616
- PMCID: PMC4553068
- DOI: 10.1016/j.coi.2015.06.015
Synthetic biology approaches to engineer T cells
Abstract
There is rapidly growing interest in learning how to engineer immune cells, such as T lymphocytes, because of the potential of these engineered cells to be used for therapeutic applications such as the recognition and killing of cancer cells. At the same time, our knowhow and capability to logically engineer cellular behavior is growing rapidly with the development of synthetic biology. Here we describe how synthetic biology approaches are being used to rationally alter the behavior of T cells to optimize them for therapeutic functions. We also describe future developments that will be important in order to construct safe and precise T cell therapeutics.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.Annu Rev Pathol. 2017 Jan 24;12:305-330. doi: 10.1146/annurev-pathol-052016-100304. Epub 2016 Dec 5. Annu Rev Pathol. 2017. PMID: 27959633 Free PMC article. Review.
-
Synthetic Immunology: Hacking Immune Cells to Expand Their Therapeutic Capabilities.Annu Rev Immunol. 2017 Apr 26;35:229-253. doi: 10.1146/annurev-immunol-051116-052302. Annu Rev Immunol. 2017. PMID: 28446063 Free PMC article. Review.
-
Synthetic biology: at the crossroads of genetic engineering and human therapeutics-a Keystone Symposia report.Ann N Y Acad Sci. 2021 Dec;1506(1):98-117. doi: 10.1111/nyas.14710. Epub 2021 Nov 16. Ann N Y Acad Sci. 2021. PMID: 34786712 Review.
-
A synthetic biology approach to engineering circuits in immune cells.Immunol Rev. 2023 Nov;320(1):120-137. doi: 10.1111/imr.13244. Epub 2023 Jul 19. Immunol Rev. 2023. PMID: 37464881 Review.
-
Emerging Cellular Therapies for Cancer.Annu Rev Immunol. 2019 Apr 26;37:145-171. doi: 10.1146/annurev-immunol-042718-041407. Epub 2018 Dec 10. Annu Rev Immunol. 2019. PMID: 30526160 Free PMC article. Review.
Cited by
-
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.J Transl Med. 2019 Jul 24;17(1):240. doi: 10.1186/s12967-019-1988-y. J Transl Med. 2019. PMID: 31340822 Free PMC article.
-
T cell circuits that sense antigen density with an ultrasensitive threshold.Science. 2021 Mar 12;371(6534):1166-1171. doi: 10.1126/science.abc1855. Epub 2021 Feb 25. Science. 2021. PMID: 33632893 Free PMC article.
-
Synthetic immunology: T-cell engineering and adoptive immunotherapy.Synth Syst Biotechnol. 2018 Sep 1;3(3):179-185. doi: 10.1016/j.synbio.2018.08.001. eCollection 2018 Sep. Synth Syst Biotechnol. 2018. PMID: 30345403 Free PMC article. Review.
-
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.Nat Nanotechnol. 2017 Aug;12(8):813-820. doi: 10.1038/nnano.2017.57. Epub 2017 Apr 17. Nat Nanotechnol. 2017. PMID: 28416815 Free PMC article.
-
Multiscale engineering of immune cells and lymphoid organs.Nat Rev Mater. 2019 Jun;4(6):355-378. doi: 10.1038/s41578-019-0100-9. Epub 2019 Apr 3. Nat Rev Mater. 2019. PMID: 31903226 Free PMC article.
References
-
- Purnick PE, Weiss R. The second wave of synthetic biology: from modules to systems. Nat Rev Mol Cell Biol. 2009;10(6):410–422. - PubMed
-
- Way JC, Collins JJ, Keasling JD, Silver PA. Integrating biological redesign: where synthetic biology came from and where it needs to go. Cell. 2014;157(1):151–161. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical